PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,198 | +419.8% | 312 | +447.4% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 57 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 57 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -90.9% | 57 | -75.2% | 0.00% | – |
| Q2 2021 | $11,000 | +120.0% | 230 | +19.2% | 0.00% | – |
| Q1 2021 | $5,000 | -79.2% | 193 | -83.3% | 0.00% | – |
| Q4 2020 | $24,000 | +118.2% | 1,159 | +113.4% | 0.00% | – |
| Q3 2020 | $11,000 | -93.8% | 543 | -94.6% | 0.00% | -100.0% |
| Q2 2020 | $178,000 | +17700.0% | 10,083 | +12048.2% | 0.00% | – |
| Q1 2020 | $1,000 | – | 83 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |